Publication List



Bernardo Cortese


Publication List


Book's titleName of EditorDate of PublicationLink (if online)
Drug-coated Balloons: Applications in Interventional Cardiology, II EdSpringer International Publishing AGprov. 2025
HRB PatientSpringer International Publishing AGprov. 2024
Percutaneous management of coronary artery disease, beyond stents – The future is nowEdizioni Minerva Medica2023
Left Main Coronary RevascularizationSpringer International Publishing AG2022
Drug-Coated balloons-The “leave nothing behind” strategyIMR Press, Reviews in Cardiovascular Medicine2021 Sep 31https://www.imrpress.com/journal/RCM/special_issues/1617687400166
Drug-coated Balloons: Applications in Interventional CardiologySpringer International Publishing AG2019
The Interventional Cardiology WorldNova Medicine and Health2021
Erectile dysfunctionEdizioni Minerva Medica2021
Tips and tricks of new techniques beyond stenting - Chapter: “Coronary angioplasty with drug-coated balloons: tips & tricks”EuroPCR textbook2020
Article's titleJournal's nameDate of PublicationLink (if online)
Long-term outcomes of DCB and DES for the treatment of in-stent restenosis in relation to the vessel sizeCatheter Cardiovasc Interv.2024 Oct 9https://pubmed.ncbi.nlm.nih.gov/39381995/
Is intravascular ultrasound needed to optimize drug-coated balloon angioplasty results?Eur Heart J
.
2024 Sep 25https://pubmed.ncbi.nlm.nih.gov/39319641/
Coronary Drug-Coated Balloons: A Comprehensive Review of Clinical Applications and ControversiesTrends Cardiovasc Med.2024 Sep 5https://pubmed.ncbi.nlm.nih.gov/39243831/
Are we at dawn of the drug-coated balloons era? Current evidence, future directions, and tasks of the newly established working group of the Association of Cardiovascular InterventionsCardiol J.2024https://pubmed.ncbi.nlm.nih.gov/39212183/
Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparisonInt J Cardiol.2024 Aug 15https://pubmed.ncbi.nlm.nih.gov/39153511/
Is Delayed Stent Fracture Possible?: A Combined Enhanced Stent Visualization and IVUS DiagnosisJACC Cardiovasc Interv2024 Aug 7https://pubmed.ncbi.nlm.nih.gov/39297857/
Magic Touch sirolimus-coated balloon: animal and clinical evidence of a coronary sirolimus drug-coated balloonFuture Cardiol.2024 Aug 6https://pubmed.ncbi.nlm.nih.gov/39105679/
Letter: Biological differences of three paclitaxel- and sirolimus-coated balloons on coronary lesions in a rabbit modelEuroIntervention2024 Aug 5https://pubmed.ncbi.nlm.nih.gov/39099376/
Safety and efficacy of single antiplatelet therapy in a large cohort of patients treated with sirolimus-coated balloon: Post hoc analysis from the prospective EASTBOURNE registryCardiovasc Revasc Med.2024 Jul 30https://pubmed.ncbi.nlm.nih.gov/39191613/
Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis-DM-Dragon RegistryJ Clin Med.2024 Jul 30https://pubmed.ncbi.nlm.nih.gov/39124731/
Navigating challenges in drug-coated balloon technology: The saga between paclitaxel and sirolimus continuesCatheter Cardiovasc Interv.2024 Jul 30https://pubmed.ncbi.nlm.nih.gov/39077789/
Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: A subanalysis of the EASTBOURNE studyCardiovasc Revasc Med.2024 Jul 28https://pubmed.ncbi.nlm.nih.gov/39122570/
Gender differences in outcomes after left atrial appendage closure with Watchman FLX device: insights from the Italian-FLX registryFront Cardiovasc Med.2024 Jul 25https://pubmed.ncbi.nlm.nih.gov/39139754/
Long-Term Outcomes Following Sirolimus-Coated Balloon or Drug-Eluting Stents for Treatment of In-Stent RestenosisCirc. Cardiovasc. Interv2024 Jul 25https://pubmed.ncbi.nlm.nih.gov/39051094/
Management of patients treated with oral anticoagulant therapy undergoing percutaneous coronary intervention with stent implantation: the PERSEO Registry. J Cardiovasc Pharmacol. 2024 Jul 19https://pubmed.ncbi.nlm.nih.gov/39028879/
mTOR Inhibition by Drug-Coated Balloon: A Thor's Hammer Against Atherosclerosis?JACC Cardiovasc Interv.2024 Jul 8https://pubmed.ncbi.nlm.nih.gov/38842999/
Two-year outcomes of sirolimus-coated balloon angioplasty for coronary artery disease: the EASTBOURNE Registry. EuroIntervention. 2024 Jul 1https://pubmed.ncbi.nlm.nih.gov/38949239/
New Drug-Coated Balloons on the Horizon: The Quest for a Good Balance Between Safety and EfficacyJACC Basic Transl Sci.2024 Jun 24https://pubmed.ncbi.nlm.nih.gov/39070277/
Long-term outcomes following paclitaxel-coated balloons versus thin-strut drug eluting stents for treatment of in-stent restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry). Kardiol Pol. 2024 Jun 18https://pubmed.ncbi.nlm.nih.gov/38887780/
mTOR Inhibition by Drug-Coated Balloon: A Thor's Hammer Against Atherosclerosis?JACC Cardiovasc Interv2024 May 25https://pubmed.ncbi.nlm.nih.gov/38842999/
Editorial: Is the axiom of balloon angioplasty, "the more you gain the more you lose", still true in the era of DCB with paclitaxel?Cardiovasc Revasc Med. 2024 Apr 6https://pubmed.ncbi.nlm.nih.gov/38664133/
Drug-Coated Balloon in Acute Coronary Syndromes: Ready for the Prime Time?Curr Cardiol Rep.2024 Mayhttps://pubmed.ncbi.nlm.nih.gov/38619711/
The role of drug-coated balloons for coronary bifurcation management: results from the prospective EASTBOURNE-BIF study.Minerva Cardiol Angiol. 2024 Mar 29https://pubmed.ncbi.nlm.nih.gov/38551600/
A 2024 scientific update on the clinical performance of drug-coated balloons.AsiaIntervention. 2024 Feb 29https://pubmed.ncbi.nlm.nih.gov/38425817/
Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels.Catheter Cardiovasc Interv. 2024 Mar https://pubmed.ncbi.nlm.nih.gov/38415895/
Long-term impact of intravascular ultrasound-guided for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study. Int J Cardiol. 2024 Feb 14https://pubmed.ncbi.nlm.nih.gov/38365014/
EASTBOURNE investigators. Sirolimus-coated balloon in all-comer population of coronary artery disease patients: the EASTBOURNE DIABETES prospective registry. Cardiovasc Diabetol.2024 Feb 3https://pubmed.ncbi.nlm.nih.gov/38310281/
Performance of sodium-glucose cotransporter 2 inhibitors in cardiovascular disease. J Cardiovasc Med (Hagerstown). 2024 Feb 1https://pubmed.ncbi.nlm.nih.gov/38305141/
Corrigendum to 'Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score' [American Journal of Cardiology 206 (2023) 320-329]. Am J Cardiol. 2023 Dec 16https://pubmed.ncbi.nlm.nih.gov/38114059/
Long-term benefits of drug-coated balloons for coronary artery revascularization. Minerva Cardiol Angiol. 2023 Dec 21https://pubmed.ncbi.nlm.nih.gov/38127439/
Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry. Int J Cardiol. 2024 Feb 15https://pubmed.ncbi.nlm.nih.gov/38061607/
How to perform a successful drug-coated balloon angioplasty? Tips and tricks. Catheter Cardiovasc Interv. 2023 Dechttps://pubmed.ncbi.nlm.nih.gov/37948409/
The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study.Catheter Cardiovasc Interv. 2023 Nov 8https://pubmed.ncbi.nlm.nih.gov/37937671/
A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels.JACC Cardiovasc Interv. 2023 Oct 17https://pubmed.ncbi.nlm.nih.gov/37877914/
The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data.Catheter Cardiovasc Interv. 2023 Oct 23https://pubmed.ncbi.nlm.nih.gov/37870079/
Coronary Calcification In Patients Presenting With Acute Coronary Syndromes: Insights From The Matrix Trial.
Eur Heart J Acute Cardiovasc Care. 2023 Oct 9https://pubmed.ncbi.nlm.nih.gov/37812760/
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment.
J Clin Med2023 Sep 8https://pubmed.ncbi.nlm.nih.gov/37762785/
Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score.Am J Cardiol2023 Sep 19https://pubmed.ncbi.nlm.nih.gov/37734293/
Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.Catheter Cardiovasc Interv. 2023 Sep 5https://pubmed.ncbi.nlm.nih.gov/37668085/
Clinical outcomes of a dedicated bifurcation stent system.Cardiovasc Revasc Med. 2023 Sep 5https://pubmed.ncbi.nlm.nih.gov/37668085/
Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome.JACC Cardiovasc Interv. 20232023 Aug 14https://pubmed.ncbi.nlm.nih.gov/37587595/
Comparison of Outcomes Betweenacurate 1-Stent and 2-Stent Techniques for Medina Classification 0.0.1 Coronary Bifurcation Lesions. JACC Cardiovasc Interv. 2023 Jul 4https://pubmed.ncbi.nlm.nih.gov/37565964/
Contrast-zero transcatheter aortic valve replacement with ACURATE neo2™ system in patients with severe chronic kidney disease.Minerva Cardiol Angiol.2023 Aug 4https://pubmed.ncbi.nlm.nih.gov/37539676/
Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry.JACC Cardiovasc Interv. 2023 Jul 24https://pubmed.ncbi.nlm.nih.gov/37495352/
Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry.
J Am Heart Assoc.2023 Aug 12https://pubmed.ncbi.nlm.nih.gov/37489724/
Coronary Sinus Reducer-in-Reducer Implantation in Treating Refractory Angina: A Case Report.JACC Cardiovasc Interv. 2023 Jul 24https://pubmed.ncbi.nlm.nih.gov/37354161/
Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM).Cardiovasc Revasc Med. 2023 Jun 6https://pubmed.ncbi.nlm.nih.gov/37328392/
Coronary Lithotripsy as Elective or Bail-Out Strategy After Rotational Atherectomy in the Rota-Shock Registry.Am J Cardiol.2023 Jul 1https://pubmed.ncbi.nlm.nih.gov/37182254/
Calcific lesions are the last frontier of endovascular therapies.Catheter Cardiovasc. Interv.2023 May 1https://pubmed.ncbi.nlm.nih.gov/37087671/
Coronary stent failure: role of a blended approach with drug-coated balloons for complex lesions.Minerva Cardiol Angiol.2023 Mar 20https://pubmed.ncbi.nlm.nih.gov/36939731/
Long term follow up a RCT of DCB vs EES in small coronary vessels. The PICCOLETO II long term study.JACC Cardiovasc Interv. 2023 May 8
Effect of single antiplatelet therapy after DCB angioplastyJAHA2023 Mar 21https://www.ahajournals.org/doi/10.1161/JAHA.122.028413
Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative project.Front Cardiovascolare Med.2023 Jan 11https://pubmed.ncbi.nlm.nih.gov/36712245/
Long-term outcomes following intravascular lithotripsy (IVL) for calcified coronary lesions: A Real-World Multicenter European Study.Catheter Cardiovasc Interv. 2022 Dec 16https://pubmed.ncbi.nlm.nih.gov/36525378/
Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions.JACC Asia2022 Sep 20https://pubmed.ncbi.nlm.nih.gov/36518719/
"Spontaneous" Coronary Artery Dissection After SARS-CoV-2 Messenger RNA Vaccination.J Soc Cardiovasc Angiogr Interv. 2022 Dec 5https://pubmed.ncbi.nlm.nih.gov/36504691/
Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States.Am J Cardiol Angiol.2022 Nov 2https://pubmed.ncbi.nlm.nih.gov/36321887/
The role of optical coherence tomography in guiding percutaneous coronary interventions- is left main the final challenge?Minerva Cardiol Angiol2022 Nov 2https://pubmed.ncbi.nlm.nih.gov/36321887/
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.Int J Cardiol.2022 Oct 25https://pubmed.ncbi.nlm.nih.gov/36306949/
Intravascular imaging for left main stem assessment: An update on the most recent clinical data.Catheter Cardiovasc Interv.2022 Oct 23https://pubmed.ncbi.nlm.nih.gov/36273435/
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry.
Front Cardiovasc. Med.2022 Sep 28https://pubmed.ncbi.nlm.nih.gov/36247479/
Design of the PERSEO Registry on the management of patients treated with oral anticoagulants and coronary stent.
J Cardiovasc Med (Hagerstown)2022 Nov 1https://pubmed.ncbi.nlm.nih.gov/36166340/
Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.Catheter Cardiovascular Interv.2022 Octhttps://pubmed.ncbi.nlm.nih.gov/36054266/
Pregnancy and Spontaneous Coronary Artery Dissection: Lessons From Survivors and Nonsurvivors.Circulation2022 Jun 3https://pubmed.ncbi.nlm.nih.gov/35656808/
Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms.J Pers Med2022 Jun 17https://pubmed.ncbi.nlm.nih.gov/35743777/
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry.J Am Heart Assoc.2022 Jun 22https://pubmed.ncbi.nlm.nih.gov/35730631/
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry.Int J Clin Pract2022 May 26https://pubmed.ncbi.nlm.nih.gov/35685504/
Drug-Coated Balloons for Unselected Real World Patients: Are We There Yet?Korean Circ J2022 Junhttps://pubmed.ncbi.nlm.nih.gov/35656903/
Letter to the editor-is FAME 3 trial providing answers or rising more questions?Cardiovasc Revasc Med2022 May 17https://pubmed.ncbi.nlm.nih.gov/35643852/
Which pre-dilatation balloons provide the best lesion preparation prior to use of drug coated balloons in De Novo lesions? Results from the PREPARE study.Minerva Cardiol Angiol2022 Apr 14https://pubmed.ncbi.nlm.nih.gov/35420280/
Safety and efficacy of systematic lesion preparation with a novel generation Scoring Balloon in complex percutaneous interventions: results from a prospective registry.Minerva Cardiol Angiol2022 Mar 28https://pubmed.ncbi.nlm.nih.gov/35343174/
Balloon aortic valvuloplasty review: the revenge during COVID-19 outbreak?Minerva Cardiol Angiol2022 Mar 25https://pubmed.ncbi.nlm.nih.gov/35332746/
Coronary lithotripsy for the treatment of underexpanded stents; the international multicentre CRUNCH registry.
EuroIntervention2022 Mar 23https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241293/
Intravascular Imaging for Peripheral Artery Interventions: Ready for Prime Time?JACC Cardiovasc Interv.2022 May 14https://pubmed.ncbi.nlm.nih.gov/35287160/
Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI STRATEGY-IT long-term.J Cardiovasc Med (Hagerstown)2022 Apr 1https://pubmed.ncbi.nlm.nih.gov/35287160/
Efficacy and safety of a dedicated left atrial appendage occlusion protocol.Cardiovasc Revasc Med.2022 Feb 26https://pubmed.ncbi.nlm.nih.gov/35249844/
Drug-coated balloon for the management of coronary chronic total occlusions.Rev Cardiovasc Med.2022 Jan 24https://pubmed.ncbi.nlm.nih.gov/35229533/
DCBs as an adjuvant tool to DES for very complex coronary lesions.Rev Cardiovasc Med2022 Jan 14https://pubmed.ncbi.nlm.nih.gov/35092205/
Should paclitaxel be considered an old generation DCB? The limus era.Rev Cardiovasc Med2021 Dec 22https://pubmed.ncbi.nlm.nih.gov/34957773/
Excimer laser prior to drug-coated balloon treatment of in-stent restenosis.Int J Cardiol2022 Feb 1https://pubmed.ncbi.nlm.nih.gov/34864077/
Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis.J Invasive Cardiol2021 Novhttps://pubmed.ncbi.nlm.nih.gov/34735352/
Back to the future: DCB use instead of DES for the treatment of complex, native coronary artery disease.Our Heart J Suppl.2021 Oct 8https://pubmed.ncbi.nlm.nih.gov/34650357/
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data.Med Clin (Engl Ed)2021 Oct 8https://pubmed.ncbi.nlm.nih.gov/34632069/
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry.Heart2022 Janhttps://pubmed.ncbi.nlm.nih.gov/34611045/
RENASCENT III: First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-Month Imaging and 2-Year Clinical Results.Circa Cardiovasc Interv.2021 Mayhttps://pubmed.ncbi.nlm.nih.gov/34003665/
Intravascular Lithotripsy and Dual Drug-Coated Balloons for the Treatment of Severely Calcific Renal In-Stent Restenosis: All Is Fair in War.Cardiovascolare Revasc Med2021 Julhttps://pubmed.ncbi.nlm.nih.gov/34031006/
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data.
Med Clin (Barc)2021 Oct 8https://pubmed.ncbi.nlm.nih.gov/34154809/
Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry).Am J Cardiol2021 Oct 1https://pubmed.ncbi.nlm.nih.gov/34325877/
Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry).Am J Cardiol2021 Oct 1https://pubmed.ncbi.nlm.nih.gov/34353628/
Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.Catheter Cardiovascular Interv.2021 Sep 8https://pubmed.ncbi.nlm.nih.gov/34582631/
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry.Heart.2021 Oct 5https://pubmed.ncbi.nlm.nih.gov/34611045/
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data.Med Clin (Engl Ed)2021 Oct 8https://pubmed.ncbi.nlm.nih.gov/34632069/
Back to the future: DCB use instead of DES for the treatment of complex, native coronary artery disease.Eur Heart J Suppl2021 Oct 8https://pubmed.ncbi.nlm.nih.gov/34650357/
Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis.J Invasive Cardiol.2021 Novhttps://pubmed.ncbi.nlm.nih.gov/34735352/
Excimer laser prior to drug-coated balloon treatment of in-stent restenosisInt J Cardiol.2021 Dec 2https://pubmed.ncbi.nlm.nih.gov/34864077/
Left main stem treatmentSpringer International Publishing AGin press
RENASCENT III: First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-Month Imaging and 2-Year Clinical ResultsCirc Cardiovasc Interv.2021 May 18https://pubmed.ncbi.nlm.nih.gov/34003665/
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry dataMedicina Clínica (Barc)2021 May 6https://pubmed.ncbi.nlm.nih.gov/34154809/#full-view-affiliation-20
Comparison Between Sirolimus- and Paclitaxel-Coated Balloon for Revascularization of Coronary Arteries: The SIRPAC (SIRolimus-PAClitaxel) StudyCardiovasc Revasc Med. 2021 Apr 17https://pubmed.ncbi.nlm.nih.gov/33888418/
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])Crit Care Med.2021 Apr 2
https://pubmed.ncbi.nlm.nih.gov/33861553/
Transradial approach for carotid artery stenting: A position paper from the Italian Society of Interventional Cardiology (SICI-GISE)Catheter Cardiovasc Interv.2021 Apr 12https://pubmed.ncbi.nlm.nih.gov/33844439/
Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registryCatheter Cardiovasc Interv. 2021 Apr 12https://pubmed.ncbi.nlm.nih.gov/33794235/
Reply: Seeking an Appropriate Primary Endpoint for Trials Comparing DCB and DES. JACC Cardiovasc Interv.2021 Mar 22 https://pubmed.ncbi.nlm.nih.gov/33736780/
Is Paclitaxel-Eluting Stent Use Justified by an Adequate Risk Profile? JACC Cardiovasc Interv.2021 Mar 22 https://pubmed.ncbi.nlm.nih.gov/33736777/
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registryInfection. 2021 Mar 1https://pubmed.ncbi.nlm.nih.gov/33646505/
Abluminus DES: a step forward in the fight against diabetes?Minerva Cardioangiol.2021 Jan 11https://pubmed.ncbi.nlm.nih.gov/33427428/
Chapter: “Coronary angioplasty with drug-coated balloons: tips & tricks”EuroPCR textbook TIPS AND TRICKS OF NEW TECHNIQUES BEYOND STENTING2020
Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical TrialJACC Cardiovasc Interv.2020 Dec 28https://pubmed.ncbi.nlm.nih.gov/33248978/
Hard Events AfteR Orsiro Sirolimus-Eluting Stent (HEROES) in STEMI: A Multicenter RegistryJ Invasive Cardiol. 2020 Dechttps://pubmed.ncbi.nlm.nih.gov/33221731/
Autoimmune Disease and Spontaneous Coronary Artery Dissection: Causation Versus CoexistenceJ Am Coll Cardiol. 2020 Nov 10https://pubmed.ncbi.nlm.nih.gov/33153583/
A Prospective Multicenter Randomized Trial to Assess the Effectiveness of the MagicTouch Sirolimus-Coated Balloon in Small Vessels: Rationale and Design of the TRANSFORM I TrialCardiovasc Revasc Med. 2020 Oct 17https://pubmed.ncbi.nlm.nih.gov/33109476/
Paclitaxel-coated balloons: Are all created equal?International Journal of Cardiology2021 Jan 1https://pubmed.ncbi.nlm.nih.gov/33091521/
ImpaCt of an optimal Implantation strategy on Absorb long-term Outcomes: the CIAO RegistryCardiovasc Revasc Med.2020 Oct 1https://pubmed.ncbi.nlm.nih.gov/33077393/
Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter studyCatheter Cardiovasc Interv. 2020 Sep 16https://pubmed.ncbi.nlm.nih.gov/32936532/
Prevalence and quantitative assessment of macrophages in coronary plaquesInt J Cardiovasc Imaging. 2020 Aug 10https://pubmed.ncbi.nlm.nih.gov/32779079/
Clinical performance of a novel sirolimus-coated balloon in coronary artery disease: EASTBOURNE registryJ Cardiovasc Med (Hagerstown)2021 Feb 1https://pubmed.ncbi.nlm.nih.gov/32740442/
Impact of stent thickness on clinical outcomes in small vessel and bifurcation lesions: a RAIN-CARDIOGROUP VII sub-studyJ Cardiovasc Med (Hagerstown)2021 Janhttps://pubmed.ncbi.nlm.nih.gov/32740419/
Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational studyCatheter Cardiovasc Interv. 2020 Jul 17https://pubmed.ncbi.nlm.nih.gov/32678493/
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trialsCatheter Cardiovasc Interv. 2020 Jun 27https://pubmed.ncbi.nlm.nih.gov/32592437/
IntravaScular Lithotripsy for the Management of UndILatable Coronary StEnt: The SMILE RegistryCardiovasc Revasc Med. 2020 Dec 21https://pubmed.ncbi.nlm.nih.gov/32580881/
COVID-19 pandemic-Some cardiovascular considerations from the trenchAm Heart J. 2020 Julhttps://pubmed.ncbi.nlm.nih.gov/32470634/
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcationsCatheter Cardiovasc Interv. 2020 May 21https://pubmed.ncbi.nlm.nih.gov/32438488/
How is the cardiovascular patient managed during Covid-19 pandemic? A report from the frontlineCatheter Cardiovasc Interv.2020 Novhttps://pubmed.ncbi.nlm.nih.gov/32433798/
Contrast-induced acute kidney injury: the long and winding roadMinerva Cardioangiol. 2020 Aprhttps://pubmed.ncbi.nlm.nih.gov/32429630/
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)BMC Cardiovasc Disord. 2020 May 15https://pubmed.ncbi.nlm.nih.gov/32414330/
Drug-coated balloons for acute myocardial infarction. Ready for prime time?EuroIntervention.2020 Apr 17https://pubmed.ncbi.nlm.nih.gov/32301710/
Long-term follow-up after sirolimus-coated balloon use for coronary artery disease. Final results of the Nanolutè studyCatheter Cardiovasc Interv. 2020 Novhttps://pubmed.ncbi.nlm.nih.gov/32191384/
First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trialEuroIntervention.2020 Jun 12https://pubmed.ncbi.nlm.nih.gov/32149709/
Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations: An Analysis From the RAIN-CARDIOGROUP VII StudyCirc Cardiovasc Interv.2020 Marhttps://pubmed.ncbi.nlm.nih.gov/32102566/
Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stentCatheter Cardiovasc Interv.2020 Sep 1https://pubmed.ncbi.nlm.nih.gov/32012453/
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary BifurcationsAm J Cardiol. 2020 Feb 15https://pubmed.ncbi.nlm.nih.gov/31889527/
Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomesCatheter Cardiovasc Interv. 2020 Julhttps://pubmed.ncbi.nlm.nih.gov/31860158/
Drug-coated Balloons: Applications in Interventional CardiologySpringer International Publishing AG2019
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary BifurcationsAm J Cardiol. 2019 Nov 23https://pubmed.ncbi.nlm.nih.gov/31889527/
Mortality Increase and Paclitaxel-Coated Device Use: A Plausible But Inconclusive HypothesisJACC Cardiovasc Interv.2019 Dec 23https://pubmed.ncbi.nlm.nih.gov/31857024/
The impact of the use of bioresorbable vascular scaffolds and drug-coated balloons in coronary bifurcation lesionsEgypt Heart J.2019 Dec 16https://pubmed.ncbi.nlm.nih.gov/31845098/
The role of optimal lesion preparation for de-novo coronary vessels when a stentless intervention strategy is plannedMinerva Cardioangiol. 2019 Nov 28https://pubmed.ncbi.nlm.nih.gov/31789010/
The hypothesis of an increased mortality following paclitaxel coated device use in peripheral vascular interventions (and the emerging era of meta-analysis based evidence)Catheter Cardiovasc Interv. 2019 Nov 19https://pubmed.ncbi.nlm.nih.gov/31743534/
Prospective evaluation of drug eluting self-apposing stent for the treatment of unprotected left main coronary artery disease: 1-year results of the TRUNC studyCatheter Cardiovasc Interv.2019 Nov 6https://pubmed.ncbi.nlm.nih.gov/31696618/
Drug-coated balloons for coronary artery disease: current concepts and controversiesFuture Cardiol. 2019 Nov https://pubmed.ncbi.nlm.nih.gov/31686536/
Radial artery perforation: when a friend turns against youEgypt Heart J.2019 Sep 11https://pubmed.ncbi.nlm.nih.gov/31659537/
Safety and effectiveness of the self-aPposing, bAlloon-delivered, siRolimus-eluting stent for the Treatment of the coronary Artery disease: SPARTA, a multicenter experienceCoron Artery Dis.2020 Jan 31https://pubmed.ncbi.nlm.nih.gov/31658146/
Role of optical coherence tomography for distal left main stem angioplastyCatheter Cardiovasc Interv.2019 Oct 21https://pubmed.ncbi.nlm.nih.gov/31631525/
Monogenic hyperlipidemiasActa Biomed. 2019 Sep 30https://pubmed.ncbi.nlm.nih.gov/31577253/
Cardiac conduction defectsActa Biomed. 2019 Sep 30https://pubmed.ncbi.nlm.nih.gov/31577249/
Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registriesCatheter Cardiovasc Interv. 2019 Aug 5https://pubmed.ncbi.nlm.nih.gov/31385427/
Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)International Journal of Cardiology2020 Jan 15https://pubmed.ncbi.nlm.nih.gov/31378382/
Dual antiplatelet therapy strategies and clinical outcomes in patients treated with polymer-free biolimus A9-coated stentsEuroIntervention. 2019 Jul 23https://pubmed.ncbi.nlm.nih.gov/31334704/
Two-year clinical outcomes of the "Italian diffuse/multivessel disease absorb prospective registry" (IT-DISAPPEARS)International Journal of Cardiology2019 Sep 1https://pubmed.ncbi.nlm.nih.gov/31104821/
Drug-coated balloons: room for development of BASKET-SMALL 2Lancet. 2019 May 11https://pubmed.ncbi.nlm.nih.gov/31084960/
Paclitaxel Drug-Coated Balloons in Peripheral Artery Disease: Who's Trying to Shoot the Football Star?Cardiovasc Revasc Med.2019 Aprhttps://pubmed.ncbi.nlm.nih.gov/31023546/
Focus on STENTYS ® Xposition S Self-Apposing ® stent: a review of available literatureFuture Cardiol.2019 Mayhttps://pubmed.ncbi.nlm.nih.gov/31023079/
Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registryJ Cardiovasc Med 2019 Julhttps://pubmed.ncbi.nlm.nih.gov/30994510/
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life)International Journal of Cardiology2019 Sep 1https://pubmed.ncbi.nlm.nih.gov/30971372/
Sirolimus-Coated Balloons: A Ferrari for Our Coronary Patients or Another Elegant Town Car?JACC Cardiovasc Interv.2019 Mar 25https://pubmed.ncbi.nlm.nih.gov/30898254/
Spontaneous Coronary Artery Dissection: Pathophysiological Insights From Optical Coherence TomographyJACC Cardiovasc Imaging.2019 Dechttps://pubmed.ncbi.nlm.nih.gov/30878439/
Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study)Am J Cardiol.2019 May 15https://pubmed.ncbi.nlm.nih.gov/30846212/
Use of Paclitaxel-Eluting Technologies in the Femoropopliteal Segment Under Scrutiny Over Possible Link to Late All-Cause Mortality: Time to Panic or an Opportunity to Resurge?J Endovasc Ther. 2019 Febhttps://pubmed.ncbi.nlm.nih.gov/30760131/
Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT studyEuroIntervention2019 May 20https://pubmed.ncbi.nlm.nih.gov/30398966/
One-year clinical performance of ABSORB bioresorbable vascular scaffold in patients presenting with acute coronary syndromes: Results from the RAI registryCatheter Cardiovasc Interv.2018 Oct 22https://pubmed.ncbi.nlm.nih.gov/30346080/
One-Year Results Following a Pre-Specified ABSORB Implantation Strategy in ST-Elevation Myocardial Infarction (BVS STEMI STRATEGY-IT Study)Cardiovasc Revasc Med.2018 Oct 4https://pubmed.ncbi.nlm.nih.gov/30314835/
Self-expandable sirolimus-eluting stents compared to second-generation drug-eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS-2 registriesCatheter Cardiovasc Interv.2018 Oct 8https://pubmed.ncbi.nlm.nih.gov/30298593/
A novel nanocarrier sirolimus-coated balloon for coronary interventions: 12-Month data from the Nanoluté RegistryCardiovasc Revasc Med. 2018 Jun 28https://pubmed.ncbi.nlm.nih.gov/30196029/
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialLancet.2018 Sep 8https://pubmed.ncbi.nlm.nih.gov/30153988/
Does Late Lumen Loss Represent a Measure of the Efficacy of Bioresorbable Scaffolds?JACC Cardiovasc Interv. 2018 Jul 23https://pubmed.ncbi.nlm.nih.gov/30025737/
Coronary artery treatment with a urea-based paclitaxel-coated balloon: the European-wide FALCON all-comers DCB Registry (FALCON Registry)EuroIntervention.2018 Jul 10https://pubmed.ncbi.nlm.nih.gov/29992902/
"Full-plastic jacket" with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413)International Journal of Cardiology2018 Sep 1https://pubmed.ncbi.nlm.nih.gov/29887475/
Paclitaxel-Eluting Stents and Aneurysm Formation, A Worrisome AssociationJACC Cardiovasc Interv. 2018 May 28https://pubmed.ncbi.nlm.nih.gov/29798773/
Clinical performance of a dedicated self-apposing stent for the treatment of left main stem disease. Results of the left Main AngioplasTy wIth a Self-apposing StEnt - the MATISSE studyCardiovasc Revasc Med. 2018 Apr 4https://pubmed.ncbi.nlm.nih.gov/29661597/
Long-term efficacy of drug-coated balloon for renal artery in-stent restenosisEgypt Heart J.2018 Marhttps://pubmed.ncbi.nlm.nih.gov/29622999/
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary SyndromesJ Am Coll Cardiol.2018 Mar 20https://pubmed.ncbi.nlm.nih.gov/29544607/
PCSK9 inhibitors: how to bridge the gap between scientific evidence and regulatory barriers?G Ital Cardiol (Rome)2018 Febhttps://pubmed.ncbi.nlm.nih.gov/29531379/
Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studiesCatheter Cardiovasc Interv.2018 Mar 7https://pubmed.ncbi.nlm.nih.gov/29513403/
Coronary Artery Fistulae: Anatomy, Diagnosis and Management StrategiesHeart Lung Circ.2018 Feb 9https://pubmed.ncbi.nlm.nih.gov/29503240/
Coronary sinus perforation during reducer implantationCatheter Cardiovasc Interv. 2018 Feb 26https://pubmed.ncbi.nlm.nih.gov/29481722/
Magic Touch®: preliminary clinical evidence with a novel sirolimus drug coated balloonMinerva Cardioangiol. 2018 Feb 19https://pubmed.ncbi.nlm.nih.gov/29458247/
Treatment of coronary artery disease with a new-generation drug-coated balloon: final results of the Italian Elutax SV rEgistry-DCB-RISEJ Cardiovasc Med (Hagerstown)2018 Mayhttps://pubmed.ncbi.nlm.nih.gov/29432400/
Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry)International Journal of Cardiology2018 May 1https://pubmed.ncbi.nlm.nih.gov/29429635/
Determinants of radiation dose during right transradial access: Insights from the RAD-MATRIX studyAm Heart J.2018 Febhttps://pubmed.ncbi.nlm.nih.gov/29421003/
Treatment of coronary bifurcation lesions: current knowledge and future perspectivesFuture Cardiol. 2018 Marhttps://pubmed.ncbi.nlm.nih.gov/29372810/
Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study)Catheter Cardiovasc Interv.2018 Jan 22https://pubmed.ncbi.nlm.nih.gov/29356269/
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access TrialJACC Cardiovasc Interv.2018 Jan 8https://pubmed.ncbi.nlm.nih.gov/29301646/
Left Main restenosis in the DES era - a call for actionCardiovasc Revasc Med. 2017 Nov 10https://pubmed.ncbi.nlm.nih.gov/29169984/
One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry)EuroIntervention2017 Oct 3https://pubmed.ncbi.nlm.nih.gov/28966155/
A Prospective Evaluation of a Pre-Specified Absorb BVS Implantation Strategy in ST-Segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT StudyJACC Cardiovasc Interv.2017 Sep 25https://pubmed.ncbi.nlm.nih.gov/28935077/
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold ThrombosisJACC Cardiovasc Interv.2017 Sep 25https://pubmed.ncbi.nlm.nih.gov/28935071/
Novel paclitaxel-coated scoring ballon for de novo complex coronary lesions-first reportCardiovasc Revasc Med. 2017 Aug 12https://pubmed.ncbi.nlm.nih.gov/28923693/
Occurrence and management of bioresorbable vascular scaffold failure in real-life studiesJ Thorac Dis. 2017 Aughttps://pubmed.ncbi.nlm.nih.gov/28894599/
First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosisCoron Artery Dis.2017 Aughttps://pubmed.ncbi.nlm.nih.gov/28574901/
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIXJ Am Coll Cardiol.2017 May 11https://pubmed.ncbi.nlm.nih.gov/28528767/
Pulse on Spontaneous Coronary Artery Dissections: Experience-Based SurveyJACC Cardiovasc Interv.2017 Jul 24https://pubmed.ncbi.nlm.nih.gov/28728664/
True Competitor of Femoral Access for Iliac Endovascular Interventions: A Radial AppraisalJ Endovasc Ther.2017 Febhttps://pubmed.ncbi.nlm.nih.gov/28095768/
Clinical and angiographic outcome of a single center, real world population treated with a dedicated technique of implantation for bioresorbable vascular scaffolds. The FAtebenefratelli Bioresorbable Vascular Scaffold (FABS) registryJ Interv Cardiol. 2017 Aug 29https://pubmed.ncbi.nlm.nih.gov/28853189/
Drug-coated balloons for the treatment of in-stent restenosis in diabetic patients: A review of currently available scientific dataCatheter Cardiovasc Interv.2017 May 22https://pubmed.ncbi.nlm.nih.gov/28544361/
Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) studyEuroIntervention2017 Aug 4https://pubmed.ncbi.nlm.nih.gov/28506937/
Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413)Catheter Cardiovasc Interv. 2017 May 13https://pubmed.ncbi.nlm.nih.gov/28500737/
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)EuroIntervention2017 Jul 20https://pubmed.ncbi.nlm.nih.gov/28504219/
First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosisCoron Artery Dis. 2017 Aughttps://pubmed.ncbi.nlm.nih.gov/28574901/
Drug-Eluting Balloon In-Stent Restenosis Treatment: Why not?Heart Lung Circ.2017 Mar 3https://pubmed.ncbi.nlm.nih.gov/28286092/
Fracture with the newer bioresorbable vascular scaffoldsCatheter Cardiovasc Interv. 2017 Mar 15https://pubmed.ncbi.nlm.nih.gov/28295999/
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesionsCardiovasc Revasc Med.2017 Mar 8https://pubmed.ncbi.nlm.nih.gov/28314675/
Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD-Matrix TrialJ Am Coll Cardiol. 2017 Mar 15https://pubmed.ncbi.nlm.nih.gov/28330794/
Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registryCardiovasc Revasc Med.2017 Mar 25https://pubmed.ncbi.nlm.nih.gov/28365415/
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main LesionsJACC Cardiovasc Interv.2017 Apr 10https://pubmed.ncbi.nlm.nih.gov/28385415/
First experience of drug-coated balloons for treatment of bioresorbable vascular scaffold restenosisCardiovasc Revasc Med. 2017 Mar 25https://pubmed.ncbi.nlm.nih.gov/28385555/
New technologies and applications for drug-coated balloonsG Ital Cardiol (Rome)2017 Febhttps://pubmed.ncbi.nlm.nih.gov/28398398/
Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry)Am J Cardiol. 2017 Jun 15https://pubmed.ncbi.nlm.nih.gov/28438304/
Should we reconsider dual antiplatelet therapy duration following bioresorbable scaffold angioplasty?J Thorac Dis.2017 Marhttps://pubmed.ncbi.nlm.nih.gov/28449432/
Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial ClubCatheter Cardiovasc Interv. 2017 May 2https://pubmed.ncbi.nlm.nih.gov/28463463/
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary InterventionJ Am Coll Cardiol. 2017 Jan 17https://pubmed.ncbi.nlm.nih.gov/28081827/
Recurrent in-stent restenosis, certainty of its origin, uncertainty about treatmentInternational Journal of Cardiology2017 Mar 1https://pubmed.ncbi.nlm.nih.gov/28038808/
Clinical outcome of coronary bifurcation management with a "fully bioresorbable" technique. Results of the multicentre BBS studyJ Am Coll Cardiol.2016 Nov 1https://pubmed.ncbi.nlm.nih.gov/27969791/
Bioresorbable vascular scaffold technology for small vessel coronary artery disease: results from the Italian multicenter RAI RegistryJ Am Coll Cardiol. 2016 Nov 1https://pubmed.ncbi.nlm.nih.gov/27969779/
Bioresorbable vascular scaffold in chronic total coronary artery occlusions: results from the RAI registryJ Am Coll Cardiol. 2016 Nov 1https://pubmed.ncbi.nlm.nih.gov/27969767/
Thirty-day Outcome Following Polymeric Bioresorbable Scaffold Implantation in 347 STEMI Patients Enrolled in the Multicenter "Registro Absorb Italiano" (RAI Registry)J Am Coll Cardiol.2016 Nov 1https://pubmed.ncbi.nlm.nih.gov/27969757/
Sirolimus Coated Balloons for the Prevention of Vascular Restenosis in small vessel disease: Insights from the Nanoluté RegistryJ Am Coll Cardiol.2016 Nov 1https://pubmed.ncbi.nlm.nih.gov/27969734/
Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatmentJ Thorac Dis. 2016 Octhttps://pubmed.ncbi.nlm.nih.gov/27867580/
Final shape of biovascular scaffolds and clinical outcome. Results from a multicenter all-comers study with intravascular imagingInternational Journal of Cardiology2017https://pubmed.ncbi.nlm.nih.gov/27865187/
A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT studyCatheter Cardiovasc Interv. 2016 Oct 24https://pubmed.ncbi.nlm.nih.gov/27774758/
Acutely malapposed bioresorbable vascular scaffold during primary angioplasty for spontaneous coronary artery dissection: Is a no-metal strategy better?International Journal of Cardiology2016 Dec 1https://pubmed.ncbi.nlm.nih.gov/27668707/
SICI-GISE Position paper: Use of Absorb BVS in clinical practiceG Ital Cardiol (Rome)2016 Octhttps://pubmed.ncbi.nlm.nih.gov/27729667/
Drug-eluting balloons in coronary interventions: the quiet revolution?Expert Opin Drug Deliv. 2016 Oct 8https://pubmed.ncbi.nlm.nih.gov/27718756/
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trialBritish Medical Journal2016https://pubmed.ncbi.nlm.nih.gov/27677503/
Acutely malapposed bioresorbable vascular scaffold during primary angioplasty for spontaneous coronary artery dissection: Is a no-metal strategy better?International Journal of Cardiology2016 Sep 17https://pubmed.ncbi.nlm.nih.gov/27668707/
First reported use of drug-coated balloon for bioresorbable in-scaffold restenosisCatheter Cardiovasc Interv. 2016 Sep 21https://pubmed.ncbi.nlm.nih.gov/27649683/
Left main stem angioplasty without metal: a new paradigm in interventional cardiology?EuroIntervention2016 Aug 20https://pubmed.ncbi.nlm.nih.gov/27542788/
Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future ApplicationsAm J Cardiovasc Drugs.2016 Aug 19https://pubmed.ncbi.nlm.nih.gov/27541144/
Intravascular imaging for spontaneous coronary artery dissection: A clinical-angiographic score may help the choiceCatheter Cardiovasc Interv. 2016 Aug 12https://pubmed.ncbi.nlm.nih.gov/27516166/
Twenty-four months of follow-up of a "biodegradable" model for coronary artery bifurcation management. Insights from optical coherence tomography of a new interventional strategyInternational Journal of Cardiology2016 Jun 29https://pubmed.ncbi.nlm.nih.gov/27448703/
Treatment of bifurcation lesions with drug-coated balloons: A review of currently available scientific dataInternational Journal of Cardiology2016 Jun 28https://pubmed.ncbi.nlm.nih.gov/27390995/
The Contemporary Pulse of Bioresorbable-Scaffold Thrombosis Among Expert OperatorsJ Am Coll Cardiol.2016 Jun 21https://pubmed.ncbi.nlm.nih.gov/27311531/
Bioresorbable vascular scaffolds in patients with acute myocardial infarction: a new step forward to optimized reperfusion?J Thorac Dis. 2016 Junhttps://pubmed.ncbi.nlm.nih.gov/27293870/
Spontaneous coronary artery dissection: A hint into its diagnosis and therapyInternational Journal of Cardiology2016 Jul 15https://pubmed.ncbi.nlm.nih.gov/27138697/
Spontaneous coronary artery dissections: A call for action for an underestimated entityInternational Journal of Cardiology2016 Jul 1https://pubmed.ncbi.nlm.nih.gov/27085122/
Biovascular scaffolds and reversible coronary aneurysmInternational Journal of Cardiology2016 Jul 1https://pubmed.ncbi.nlm.nih.gov/27070996/
Drug-Coated Balloon for Instent Restenosis in Patients at High Risk: Another Brick in the Wall of the Challenging Settings for InterventionistsAm J Cardiol. 2016 Jun 1https://pubmed.ncbi.nlm.nih.gov/27067617/
Bioresorbable scaffolds for spontaneous coronary artery dissection: The ghost of thrombosis?International Journal of Cardiology2016 Jul 1https://pubmed.ncbi.nlm.nih.gov/27060263/
Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian ExperienceCirc Cardiovasc Interv. 2016 Aprhttps://pubmed.ncbi.nlm.nih.gov/27059683/
Intravascular imaging as a tool for definite diagnosis of acute coronary syndrome caused by spontaneous coronary artery dissectionInternational Journal of Cardiology2016 Jul 1https://pubmed.ncbi.nlm.nih.gov/27057973/
A glimpse into first generation drug-eluting and bare metal stents ten years later with optical coherence tomography analysisInternational Journal of Cardiology2016 Jun 1https://pubmed.ncbi.nlm.nih.gov/27038717/
Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registryCatheter Cardiovasc Interv. 2016 Apr 1https://pubmed.ncbi.nlm.nih.gov/27038332/
Sealing spontaneous coronary artery dissection with bioresorbable vascular scaffold implantation: Data from the prospective "Registro Absorb Italiano" (RAI Registry)International Journal of Cardiology2016 Jun 1https://pubmed.ncbi.nlm.nih.gov/27019047/
DCB and Dissections: In Search of a Good Balance Between Enthusiasm and Scientific StrictnessJACC Cardiovasc Interv.2016 Mar 14https://pubmed.ncbi.nlm.nih.gov/26965943/
Side branch occlusion after bioresorbable vascular scaffold implantation: Thickness of the scaffold or large plaque burden? Another building block in the comprehension of this complicationInternational Journal of Cardiology2016 Jan 11https://pubmed.ncbi.nlm.nih.gov/26788820/
Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left With a DissectionJACC Cardiovasc Interv.2015 Dec 28https://pubmed.ncbi.nlm.nih.gov/26627997/
Is vasospasm overestimated in acute coronary syndromes presenting with non-obstructive coronary artery disease? The case for intravascular imagingInternational Journal of Cardiology2016 Jan 15https://pubmed.ncbi.nlm.nih.gov/26608014/
Paclitaxel-coated balloon exerts late vessel healing and enlargement: A documented phenomenon with optical coherence tomography analysisInternational Journal of Cardiology2016 Jan 15https://pubmed.ncbi.nlm.nih.gov/26569361/
Healing after coronary artery dissection: The effect of a drug coated balloon angioplasty in a bifurcation lesion. A lesson from intravascular ultrasound analysisInternational Journal of Cardiology 2016 Jan 15https://pubmed.ncbi.nlm.nih.gov/26520278/
Performance of bioresorbable vascular scaffolds versus cobalt-chromium everolimus eluting stent in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. A review of currently available clinical dataMinerva Cardioangiol. 2015 Oct 8https://pubmed.ncbi.nlm.nih.gov/26447989/
Immediate decision making in a case of iatrogenic dissection of left main coronary artery: A successful synergetic treatmentInternational Journal of Cardiology2016 Jan 1https://pubmed.ncbi.nlm.nih.gov/26386928/
STEMI patients and nonculprit lesions: To treat or not to treat? and when? A review of most recent literatureCatheter Cardiovasc Interv.2015 Sep 14https://pubmed.ncbi.nlm.nih.gov/26367867/
Bivalirudin or Unfractionated Heparin in Acute Coronary SyndromesN Engl J Med. 2015 Sep 10https://pubmed.ncbi.nlm.nih.gov/26324049/
Late Structural Discontinuity as a Possible Cause of Very Late Everolimus-Eluting Bioresorbable Scaffold ThrombosisJACC Cardiovasc Interv. 2015 Aug 24https://pubmed.ncbi.nlm.nih.gov/26315753/
Effects of drug-eluting stents after rotational atherectomy: evidence from a multicenter experienceJ Cardiovasc Med (Hagerstown)2015 Aug 7https://pubmed.ncbi.nlm.nih.gov/26258723/
Drug-eluting stent treatment of left main coronary artery disease: the case for a sirolimus-eluting, autoexpandable alternative. An optical coherence tomography analysisInternational Journal of Cardiology2015 Nov 15https://pubmed.ncbi.nlm.nih.gov/26188831/
Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplastyEur Heart J Acute Cardiovasc Care2015 Jul 10https://pubmed.ncbi.nlm.nih.gov/26163529/
Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-studyCatheter Cardiovasc Interv. 2015 Nov 1https://pubmed.ncbi.nlm.nih.gov/25854692/
Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning documentEur Heart J. 2015 May 24https://pubmed.ncbi.nlm.nih.gov/26009594/
Registro Absorb Italiano (BVS-RAI): an investigators-owned and -directed, open, prospective registry of consecutive patients treated with the Absorb™ BVS: study designCardiovasc Revasc Med. 2015 Jun 3https://pubmed.ncbi.nlm.nih.gov/26100975/
Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary InterventionsAm J Cardiol. 2015 Sep 1https://pubmed.ncbi.nlm.nih.gov/26100584/
Effective Treatment of Intermediate-Risk Pulmonary Embolism by Manual Thrombus Aspiration. A Report of Two CasesHeart Lung Circ.2015 Aughttps://pubmed.ncbi.nlm.nih.gov/25985738/
Drug-coated balloon without stent implantation for chronic total occlusion of coronary arteries: Description of a new strategy with an optical coherence tomography assistanceInternational Journal of Cardiology2015 Jul 15http://www.ncbi.nlm.nih.gov/pubmed/25965604
Very late bioresorbable vascular scaffold thrombosis due to late device recoilInternational Journal of Cardiology2015 Jun 15https://pubmed.ncbi.nlm.nih.gov/25889443/
Drug-coated balloon angioplasty: An intriguing alternative for the treatment of coronary chronic total occlusionsInternational Journal of Cardiology2015https://pubmed.ncbi.nlm.nih.gov/25838222/
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trialThe Lancet2015 Jun 20https://pubmed.ncbi.nlm.nih.gov/25791214/
Left main coronary artery and ostial left anterior descending coronary artery stenting in a single coronary artery during NSTEMI. The OCT responseInternational Journal of Cardiology2015 Apr 1https://pubmed.ncbi.nlm.nih.gov/25756578/
Outcomes With Cangrelor Versus Clopidogrel on a Background of Bivalirudin: Insights From the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI])JACC Cardiovasc Interv. 2015 Marhttps://pubmed.ncbi.nlm.nih.gov/25703887/
Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing intraprocedural versus post-stenting prolonged bivalirudin infusion. Rationale and design of the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT substudyEurointervention2015 Mar 22https://pubmed.ncbi.nlm.nih.gov/25692612/
Late malapposition after bare metal stent, but not bioresorbable scaffold: insights on intra-individual heterogeneity in plaque and device responseJournal of invasive cardiology2015 Aughttps://pubmed.ncbi.nlm.nih.gov/26232021/
Drug-eluting stent use after coronary atherectomy: results from a multicentre experience - The ROTALINK I studyJ Cardiovasc Med (Hagerstown)2016 Sephttps://pubmed.ncbi.nlm.nih.gov/25575276/
A new, intriguing hypothesis: does bivalirudin reduce the risk of acute kidney disease?Am J Cardiol. 2015 Feb 15https://pubmed.ncbi.nlm.nih.gov/25547938/
Late coronary BVS malapposition and aneurysm: A Time for AppraisalCatheter Cardiovasc Interv.2014 Dec 13https://pubmed.ncbi.nlm.nih.gov/25504909/
Current know how on the absorb BVS technology: an experts' surveyInternational Journal of Cardiology2015 Feb 1https://pubmed.ncbi.nlm.nih.gov/25463365/
Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX programAm Heart J. 2014 Dechttps://pubmed.ncbi.nlm.nih.gov/25458646/
Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre "Registro ABSORB Italiano" (RAI registry)EuroIntervention2014 Oct 30https://pubmed.ncbi.nlm.nih.gov/25354760/
The conundrum of antithrombotic drugs before, during and after primary PCIEuroIntervention2014 Aughttps://pubmed.ncbi.nlm.nih.gov/25256536/
Biovascular scaffolding of distal left main trunk: experience and follow up from the multicenter prospective RAI registry (Registro Italiano Absorb)International Journal of Cardiology2014 Dec 15https://pubmed.ncbi.nlm.nih.gov/25205485/
Comparison of risk of acute kidney injury after primary percutaneous coronary interventions with the transradial approach versus the transfemoral approach (from the PRIPITENA urban registry)Am J Cardiol.2014 Sep 15https://pubmed.ncbi.nlm.nih.gov/25073568/
The TASTE studyG Ital Cardiol (Rome)2014 Aprhttps://pubmed.ncbi.nlm.nih.gov/24873807/
Safety and feasibility of iliac endovascular interventions with a radial approach. Results from a multicenter study coordinated by the Italian Radial ForceInternational Journal of Cardiology2014 Aug 1https://pubmed.ncbi.nlm.nih.gov/24861256/
One-year follow-up of patients treated with new-generation polymer-based 38 mm everolimus-eluting stent: the P38 studyCatheter Cardiovasc Interv. 2015 Feb 1https://pubmed.ncbi.nlm.nih.gov/24824088/
Coronary dissection at site of recent BRS deployment: a case for the comeback kid?International Journal of Cardiology2014 Jul 1https://pubmed.ncbi.nlm.nih.gov/24801095/
Randomized comparison of operator radiation exposure comparing transradial and transfemoral approach for percutaneous coronary procedures: rationale and design of the minimizing adverse haemorrhagic events by TRansradial access site and systemic implementation of angioX - RAdiation Dose study (RAD-MATRIX)Cardiovasc Revasc Med. 2014 Mar 26https://pubmed.ncbi.nlm.nih.gov/24746599/
Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosisInternational Journal of Cardiology2014 May 15https://pubmed.ncbi.nlm.nih.gov/24717326/
Bioresorbable scaffolding after drug-coated balloons: a new chapter of the "leave nothing behind" sagaInternational Journal of Cardiology2014 May 15https://www.ncbi.nlm.nih.gov/pubmed/24704408
Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patientsAtherosclerosis2014 Marhttps://pubmed.ncbi.nlm.nih.gov/24529148/
Bivalirudin or heparin in primary angioplasty performed through the transradial approach: results from a multicentre registryEur Heart J Acute Cardiovasc Care2014 Jan 15https://pubmed.ncbi.nlm.nih.gov/24399486/
Scientific foundation and possible implications for practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site andSystemic Implementation of AngioX (MATRIX) trialJ Cardiovasc Transl Res. 2014 Febhttps://www.ncbi.nlm.nih.gov/pubmed/24395497
Radial versus femoral approach comparison in percutaneous coronary intervention with intraaortic balloon pump support: the RADIAL PUMP UP registryAm Heart J.2013 Dechttps://pubmed.ncbi.nlm.nih.gov/24268216/
SICI-GISE position paper on drug-coated balloon use in the coronary districtG Ital Cardiol (Rome)2013 Octhttps://www.ncbi.nlm.nih.gov/pubmed/24121894
Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional CardiologyCatheter Cardiovasc Interv. 2013 Aug 9https://www.ncbi.nlm.nih.gov/pubmed/23934956
Design of the ROSuvastatin Pretreatment to Reduce Embolization during Carotid Artery Stenting (ROSPREC) trialJ Cardiovasc Med (Hagerstown)2013https://pubmed.ncbi.nlm.nih.gov/24922046/
Distal embolization during carotid stenting is predicted by circulating levels of LDL cholesterol and C-reactive proteinEurointervention 2014 Aughttps://pubmed.ncbi.nlm.nih.gov/25138189/
How should I treat a BVS restenosis?Eurointervention2013 (in press)
How did I treat the BVS restenosis?Eurointervention2013(in press)
Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationshipJ Cardiovasc Med (Hagerstown)2013 Jun 27https://pubmed.ncbi.nlm.nih.gov/23811842/
Late catch-up phenomenon after drug-eluting balloon angioplastyInternational Journal of Cardiology2013 Sep 30https://pubmed.ncbi.nlm.nih.gov/23684563/
Modified Chimney Technique for the Emergent Treatment
of Abdominal Aortic Graft Rupture: A Cardiologist’s Point of ViewInt J Cardiovasc Research2012https://www.scitechnol.com/modified-chimney-technique-for-emergent-treatment-abdominal-aortic-graft-rupture-cardiologists-point-view-Yhnj.php?article_id=366
Percutaneous coronary interventions in patients on dialysis, the son of a forgotten child?Circulation2012
The future is now- comment on a recent editorial suggesting the need for a new technology in the treatment of DES restenosisJACC Cardiovascular Interventions2012 Octhttps://pubmed.ncbi.nlm.nih.gov/23078743/
Transradial percutaneous iliac intervention, a feasible alternative to the transfemoral routeCardiovascular Revascularization Medicine2012 Novhttps://pubmed.ncbi.nlm.nih.gov/23040183/
Current clinical application of direct thrombin inhibitors in angina pectorisScientific basis of healthcare: Angina Pectoris (book Chapter), Science Publisher2011https://www.taylorfrancis.com/chapters/edit/10.1201/b11664-11/current-clinical-application-direct-thrombin-inhibitors-angina-pectoris
Paclitaxel coated balloons, the time for awareness has comeInternational Journal of Cardiology2012 May 31https://pubmed.ncbi.nlm.nih.gov/22658568/
Bivalirudin has its own shelf in the cath lab, eventuallyInternational Journal of Cardiology2012 Feb 20https://pubmed.ncbi.nlm.nih.gov/22357425/
In the bivalirudin era, are we still looking for a potent antiplatelet agent?Curr Vasc Pharmacol.2012 Julhttps://pubmed.ncbi.nlm.nih.gov/22339254/
Current antithrombotic management of ST elevation acute coronary syndromes in the cath lab--a paradigm shiftCurr Vasc Pharmacol. 2012 Julhttps://pubmed.ncbi.nlm.nih.gov/22339251/
Paclitaxel coated balloons for coronary artery interventions: A comprehensive review of preclinical and clinical dataInternational Journal of Cardiology2011 Sept 26https://pubmed.ncbi.nlm.nih.gov/21955612/
The original sin committed in years two thousandJ Interv Cardiol2011 Oct 24https://pubmed.ncbi.nlm.nih.gov/21929731/
Effect of Prolonged Bivalirudin Infusion on ST-Segment Resolution Following Primary Percutaneous Coronary Intervention (from the PROBI VIRI 2 Study)Am J Cardiol2011 Nov 1https://www.sciencedirect.com/science/article/abs/pii/S0002914911022259
Increased basal coronary blood flow as a cause of reduced flow reserve in diabetic patientsAm J Phisiol Heart Physiol2011 Oct 7https://pubmed.ncbi.nlm.nih.gov/21984541/
Transradial percutaneous coronary interventions using sheathless guiding catheters: a multicenter registryJournal of Interventional Cardiology, vol 24, n° 5,2011https://pubmed.ncbi.nlm.nih.gov/21895772/
Transradial primary PCI: this is the time for awarenessHeart2011 Nov https://pubmed.ncbi.nlm.nih.gov/21917662/
The PICCOLETO study and beyondEurointervention2011 Mayhttps://pubmed.ncbi.nlm.nih.gov/22027728/
Paclitaxel-coated Balloons in Native Coronary Arteries: A Step Back?Treatment Strategies in Interventional Cardiology, Vol I, Issue 12011 Apr
Drug-eluting stents perform better than bare metal stents in small coronary vessels: A meta-analysis of randomised and observational clinical studies with mid-term follow upInternational Journal of Cardiology2011 May 12https://www.ncbi.nlm.nih.gov/books/NBK116960/
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trialLancet. 2011 Apr 23https://read.qxmd.com/read/21470671/radial-versus-femoral-access-for-coronary-angiography-and-intervention-in-patients-with-acute-coronary-syndromes-rival-a-randomised-parallel-group-multicentre-trial
Rationale and design of the randomized, multicenter EREMUS trial, a study that investigates how to achieve low restenosis and early reendothelialization after percutaneous coronary interventionsCatheter Cardiovasc Interv. 2011 Mar 16https://pubmed.ncbi.nlm.nih.gov/21413116/
Intracoronary drugs during percutaneous interventions: the highway has different lanes! Cardiovasc Med (Hagerstown)2010 Aug 20https://pubmed.ncbi.nlm.nih.gov/20733509/
Usefulness of primary angioplasty in nonagenarians with acute myocardial infarctionAm J Cardiol.2010 Sep 15https://pubmed.ncbi.nlm.nih.gov/20816115/
Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomized trial. The PICCOLETO studyHeart2010 Aughttps://pubmed.ncbi.nlm.nih.gov/20659948/
A comment on ‘Laboratory monitoring of new anticoagulants’American Journal of Hematology2010 Julhttps://pubmed.ncbi.nlm.nih.gov/20575040/
Transradial access compared with femoral puncture closure devices in percutaneous coronary procedures": an underestimated revolutionInternational Journal of Cardiology2010 Mar 4https://pubmed.ncbi.nlm.nih.gov/20207032/
Optimal Dual Antiplatelet Treatment after Drug-Eluting Stent Implantation: it's Not the Time for WeaningAmerican Journal of Cardiology2010 Apr 1https://pubmed.ncbi.nlm.nih.gov/20346333/
Coronary bifurcation lesions: innovative approaches and the future of bifurcation devicesFuture Cardiology2010 Marhttps://pubmed.ncbi.nlm.nih.gov/20346333/
Radial ForceHeart2010 Julhttps://pubmed.ncbi.nlm.nih.gov/20483899/
Intravenous platelet blockade with cangrelor during PCIN Eng J Med2009 Dec 10https://pubmed.ncbi.nlm.nih.gov/19915222/
Contrast-enhanced sonography in the diagnosis of acute mesenteric ischemia: case reportJ Clin Ultrasound2009 Dec 10https://pubmed.ncbi.nlm.nih.gov/20013893/
Acute Mesenteric Ischemia: Primary Percutaneous TherapyCatheterization and Cardiovascular Interventions2010 Feb 1https://pubmed.ncbi.nlm.nih.gov/19795499/
Are we sure we have taken the best from clopidogrel?American Heart Journal2009 Octhttps://pubmed.ncbi.nlm.nih.gov/19781404/
Comparison of Prolonged Bivalirudin Infusion Versus Intraprocedural in Preventing Myocardial Damage After Percutaneous Coronary Intervention in Patients with Angina Pectoris. The PROBI VIRI StudyAmerican Journal of Cardiology2009 Octhttps://pubmed.ncbi.nlm.nih.gov/19801025/
Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex PCI. A descriptive studyCoronary Artery Disease2009 Jun 18https://pubmed.ncbi.nlm.nih.gov/19543084/
A New Technique for the Treatment of Bifurcation Lesions: Modified Reverse CrushingIndian Heart Journal2008https://pubmed.ncbi.nlm.nih.gov/19276508/
Combined, superselective pharmacological management of large coronary thrombus burdenJournal of Invasive Cardiology2009 Aprhttps://pubmed.ncbi.nlm.nih.gov/19342755/
Safety and efficacy of a prolonged bivalirudin infusion after urgent PCIMinerva Medica, vol 99, suppl I, n° 52008 Oct
Intracoronary bivalirudin for no reflow reversal: a second chance to treat this disorder?J Thromb Thrombolysis2008 Jul 3https://pubmed.ncbi.nlm.nih.gov/18597045/
Acute ST-elevation Myocardial Infarction in a 15-year-old boy with celiac disease and multifactorial thrombotic risk: a case reportThrombosis and Haemostasis2008 Jun
Adjunctive Use of the Rinspiration System for Fluidic Thrombectomy During Primary Angioplasty: the Rinspiration International RegistryCatheterization and Cardiovascular Interventions2008 Aug 1https://pubmed.ncbi.nlm.nih.gov/18655122/
Thrombectomy for thrombus removal, filter for whatever elseJournal of Cardiovascular Medicine2008 Aprhttps://pubmed.ncbi.nlm.nih.gov/18334898/
Intracoronary Bivalirudin for no-reflow reversal2007 Nov 19
Transient left ventricular apical ballooning syndrome: all that glitters is not apicalJ Cardiovasc Med (Hagerstown)2007 Novhttps://pubmed.ncbi.nlm.nih.gov/17906479/
Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery,An Intravascular Ultrasound StudyJournal Of The American College Of Cardiology2007 Feb 6https://pubmed.ncbi.nlm.nih.gov/17276176/
Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitorsInternational Journal of Cardiology2007 Apr 10https://pubmed.ncbi.nlm.nih.gov/17433463/
Coronary embolization of a proximal vessel due to retrieval of a balloon catheter with an organized thrombus during primary PCIInternational Journal of Cardiology2007 Feb 12https://pubmed.ncbi.nlm.nih.gov/17303265/
Coronary Embolization of a Proximal Vessel During Primary PCIInternational Journal of Cardiology2006 Oct 3https://pubmed.ncbi.nlm.nih.gov/17303265/
Successful treatment of acute myocardial infarction due to subocclusive thrombosis over a small atheroscerotic plaque with the "Rinspiration" device, a novel thrombectomy catheterInternational Journal of Cardiology2007 Jan 31https://pubmed.ncbi.nlm.nih.gov/16740327/
Rinspirate IT clinical registryFinal Rinspirate IT report2006 Mar 12
Markers precoci di ischemia miocardicaCardiology Science, vol 412006 May-Junhttps://sicoa.net/old/cardiology/Rivista20/rassegnedecarlo.pdf
La gestione del paziente scompensato: il ruolo del medico di medicina generale in accordo con il cardiologoPrimula Edizioni (book chapter)2002https://www.ibs.it/gestione-del-paziente-scompensato-ruolo-libro-rita-mariotti/e/9788887344486
Obesity, weight loss and heart failureEuropean Heart Journal Supplements, volume 62004 Novhttps://academic.oup.com/eurheartjsupp/article/6/suppl_F/F87/422487?login=true
Echocardiographic evaluation in type 1 diabetic patients on waiting list for isolated pancreas or kidney-pancreas transplantationTransplant. Proc.2004 Aprhttps://pubmed.ncbi.nlm.nih.gov/15110556/
Gente di palestra (capitolo “intervista sul Doping in Italia”)Bradipoli (book chapter)2005http://www.bradipolibri.it
Influence of right ventricular function on clinical conditions in Heart FailureEuropean Journal of Heart Failure Suppl, vol 3, Iss 1, pag 1322004




Bernardo Cortese, MD
September 2024